Literature DB >> 12321390

Prescribing policy for antimalarials.

R Chitakata, A K Khare, C Blickling.   

Abstract

Keywords:  Africa; Africa South Of The Sahara; Developing Countries; Diseases; Distributional Activities; Drugs; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Laboratory Examinations And Diagnoses; Malaria; Malawi; Organization And Administration; Parasitic Diseases; Physical Examinations And Diagnoses; Policy; Prescriptions; Program Activities; Programs; Research Report; Treatment

Mesh：

Substances：

Year:  1998        PMID： 12321390

Source DB:  PubMed          Journal:  Afr Health        ISSN： 0141-9536


× No keyword cloud information.
  4 in total

1.  Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria.

Authors:  Benjamin S C Uzochukwu; Lausdeus O Chiegboka; Chibuike Enwereuzo; Usonwanne Nwosu; David Okorafor; Obinna E Onwujekwe; Nkoli P Uguru; Florence T Sibeudu; Ogochukwu P Ezeoke
Journal:  BMC Public Health       Date:  2010-08-16       Impact factor: 3.295

2.  Adherence to treatment guidelines for uncomplicated malaria at two public health facilities in Nigeria; Implications for the 'test and treat' policy of malaria case management.

Authors:  Charles C Ezenduka; Mathew J Okonta; Charles O Esimone
Journal:  J Pharm Policy Pract       Date:  2014-11-14

3.  Do frontline health care providers know enough about artemisinin-based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan.

Authors:  Abeer A Mannan; Khalid A Elmardi; Yassir A Idris; Jonathan M Spector; Nahid A Ali; Elfatih M Malik
Journal:  Malar J       Date:  2015-03-26       Impact factor: 2.979

4.  Malaria treatment perceptions, practices and influences on provider behaviour: comparing hospitals and non-hospitals in south-east Nigeria.

Authors:  Obinna Onwujekwe; Benjamin Uzochukwu; Nkem Dike; Nkoli Uguru; Emmanuel Nwobi; Elvis Shu
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.